137 related articles for article (PubMed ID: 1302164)
1. Cardioprotection and ACE inhibitors.
Ball SG
Clin Physiol Biochem; 1992; 9(3):98-104. PubMed ID: 1302164
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
Young JB
Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
[TBL] [Abstract][Full Text] [Related]
3. [Trials with ACE-inhibitors in acute myocardial infarction].
Dalla Volta S
Cardiologia; 1994 Dec; 39(12 Suppl 1):149-55. PubMed ID: 7634258
[TBL] [Abstract][Full Text] [Related]
4. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
Borghi C; Cosentino E; De Sanctis D
Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
[TBL] [Abstract][Full Text] [Related]
5. [Angiotensin converting enzyme inhibitors during acute phase of myocardial infarct].
Mazzotta G; Vecchio C
G Ital Cardiol; 1994 Jan; 24(1):59-70. PubMed ID: 8200499
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
7. [Indications for ACE inhibitors in the postinfarct period].
Ertl G; Gaudron P; Neubauer S; Hu K; Zdrojewski T; Horn M; Kochsiek K
Z Kardiol; 1994; 83 Suppl 4():65-74. PubMed ID: 7856283
[TBL] [Abstract][Full Text] [Related]
8. [Angiotensin converting enzyme inhibitors in arterial hypertension].
Ramón González-Juanatey J
Rev Esp Cardiol; 1999; 52 Suppl 3():73-8. PubMed ID: 10614152
[TBL] [Abstract][Full Text] [Related]
9. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
Milicić D
Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
[TBL] [Abstract][Full Text] [Related]
10. [ACE-inhibitors and cardiovascular protection].
Agabiti-Rosei E; Muiesan ML
Cardiologia; 1994 Dec; 39(12 Suppl 1):139-47. PubMed ID: 7634257
[TBL] [Abstract][Full Text] [Related]
11. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
[TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
13. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
14. RAS inhibition in hypertension.
Ibrahim MM
J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
[TBL] [Abstract][Full Text] [Related]
15. [ACE-inhibitors after infarction: current knowledge and future prospects].
Penco M; Romano S; Fedele F; Dagianti A
Cardiologia; 1994 Dec; 39(12 Suppl 1):191-6. PubMed ID: 7634266
[TBL] [Abstract][Full Text] [Related]
16. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
Azadpour M; Lamas GA
Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
Tokmakova M; Solomon SD
Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
[TBL] [Abstract][Full Text] [Related]
18. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
[TBL] [Abstract][Full Text] [Related]
19. Current indications for ACE inhibitors and HOPE for the future.
Burch S; Ou N
Am J Manag Care; 2002 May; 8(5):478-90; quiz 491-3. PubMed ID: 12019599
[TBL] [Abstract][Full Text] [Related]
20. The angiotensin II receptor blockers: opportunities across the spectrum of cardiovascular disease.
Weber MA
Rev Cardiovasc Med; 2002; 3(4):183-91. PubMed ID: 12556752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
